Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

Clinical trial NCT07268833 · RECRUITING

Trial details

NCT number: NCT07268833
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Status: RECRUITING
Study type: OBSERVATIONAL

Amyotrophic Lateral Sclerosis (ALS)Peripheral Neuropathies

Start date: 2024-10-24
Primary completion: 2027-04-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.